MergerLinks - MPM BIOIMPACT

Cover Image MPM BIOIMPACT

MPM BIOIMPACT

MPM BIOIMPACT

Summary

MPM BioImpact is a biotechnology investment firm with nearly three decades of experience creating and investing in companies.

Deals Overview

Total Deals3

Valued Deals2

Total Value£73M

Avg. Deal Size£36M

Sort

Greg Mayes

ManagerPresident and CEO at REUNION NEUROSCIENCE INC

Steven M. Cohen

LawyerPartner at Morgan Lewis & Bockius

Michael A. Margolis

Financial AdvisorSenior Managing Director at Oppenheimer & Co

Jennifer Longhurst

LawyerPartner at McCarthy Tetrault

Caitlin Kasunich

PR ConsultantSenior Vice President at KCSA Strategic Communications

Irina Koffler

PR ConsultantManaging Director at LifeSci Partners

Lewis Goldberg

PR ConsultantKCSA Strategic Communications

Rami Chalabi

LawyerPartner at McCarthy Tetrault

Briggs Morrison

ManagerCEO at CROSSBOW THERAPEUTICS

Geraldine Paulus

ManagerCo-Founder & Vice President of Corporate Development and Operations at CROSSBOW THERAPEUTICS

Corey Carmichael

PR ConsultantAccount Director at SmithSolve

Irena Melnikova

InvestorPartner at PFIZER VENTURES

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

Register now Sign up with LinkedIn

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.